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ABSTRACT 
Background: Renal Impairment (RI) is a common complication in patients with liver cirrhosis and ascites. Spontaneous Bacterial Peritonitis 
(SBP) a complication in cirrhosis further aggravates and worsens the scenario. Blood urea nitrogen (BUN)/creatinine ratio (BCR) is one of the 
common laboratory tests used to distinguish prerenal azotemia (PR) from acute tubular necrosis and proves to be handy in absence of other 
tests. 
Objective: To find the prevalence of renal impairment in the patients of liver cirrhosis with or without SBP. 
Design and Setting: Observational, prospective, single centre study. 
Methods: Cirrhotic patients with SBP or low Ascitic fluid protein were enrolled. RI was considered if the serum creatinine or urea or both were 
above the reference range. BCR was obtained for each patient and divided based on BCR <20 and BCR>20. Assessment of variability of BCR 
values was done by further dividing them into eight subgroups (<10, 10–15, 16–20, 21–25, 26–30, 31–35, 36-40 and >40). 
Results: 34 patients were enrolled and divided into two groups. Group A with 22 patients with SBP and group B with 12 patients with low ascitic 
fluid protein. Group A had 77.27% patients with RI and group B had 58.33%. Majority of the patients had BCR>20 group denoting a RI of PR type. 
Three patients had BCR>40 indicating towards a probable gastrointestinal haemorrhage.  
Conclusion: This study gives an idea about the common occurrence of renal impairment in the patients of liver cirrhosis and ascites which needs 
early intervention to improve the prognosis.    
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INTRODUCTION 
Cirrhosis of liver is a late stage complication due to fibrosis 
of the liver which can be due to several liver diseases, most 
commonly due to hepatitis and chronic alcoholism. With 
each insult to the liver, it tries to repair itself and with 
continuous damage and repair, scar tissue forms. With 
propagation of liver damage, the scarring increases and leads 
to cirrhosis which turns out to be irreversible.1 Patients with 
cirrhosis are at a very high risk of developing various 
complications which ultimately leads to a decreased life 
expectancy.2 Cirrhosis in presence of its associated 
complications has turned out to be a leading cause of death 
in present scenario. The common complications associated 
with cirrhosis are esophageal or other varices, ascites, 
hepatic encephalopathy, portal hypertension, hepatocellular 
carcinoma, hepatorenal syndrome, spontaneous bacterial 
peritonitis, and coagulation disorders.3 Renal failure is a 
common complication in these patients and is associated 
with increased mortality and morbidity in patients with 
cirrhosis.4 Literature search has revealed that the prevalence 
of acute kidney injury(AKI) in hospitalized patients with 
cirrhosis is estimated to be approximately 20–50%.4 
Hepatorenal syndrome (HRS) is a type of (AKI) which occurs 
Dutta et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2019; 9(1-s):286-289 
ISSN: 2250-1177                                                                                  [287]                                                                                         CODEN (USA): JDDTAO 
due to renal vasoconstriction and hypoperfusion as a result 
of extensive splanchnic vasodilatation. There is a strong 
evidence that HRS is also caused because of increased 
circulating proinflammatory cytokines like TNF-alpha and 
Interleukins.5 Hence, the present diagnostic criteria includes 
spontaneous bacterial peritonitis (SBP) as a trigger event in 
the development of HRS.6 The patients of cirrhosis with 
ascites with a previous episode of SBP or low ascitic albumin 
levels (less than 1.5g/dL) are at significant higher risk of 
developing SBP.7,8 Thus, an early diagnosis and treatment of 
SBP plays a crucial role.8 AKI in cirrhosis worsens the 
prognosis of the patient so early diagnosis and intervention 
is of utmost importance for effective management and 
improved outcome. The renal impairment can be diagnosed 
by various criteria like RIFLE (Risk Injury Failure Loss End-
stage renal disease) criteria and AKIN (Acute Kidney Injury 
Network) criteria.9 
The novel classification system, AKI in cirrhosis is defined as 
an increase in serum creatinine of 0.3 mg/dl within 48 h, or 
50% or 1.5-fold from baseline within 7 days.10 The 
International Club of Ascites (ICA) modified this new 
definition of AKI in cirrhosis, called ICA-AKI which was based 
on the percentage increase of serum creatinine from baseline 
and the peak value of serum creatinine during 
hospitalization.11,12 Early recognition of the cause of AKI, 
particularly differentiating prerenal azotemia (PRA) and 
acute tubular necrosis (ATN) is considered a critical clinical 
strategy because fluid resuscitation can  improve PRA but 
can worsen ATN.13,14  
The blood urea nitrogen (BUN)/creatinine ratio (BCR) is one 
of the common laboratory tests used to distinguish PRA and 
ATN. Liver failure can be associated with paradoxically near-
normal values of both BUN (due to decline in urea 
production by the liver) and serum creatinine (due to muscle 
wasting), despite of a significant decline in renal function 
manifested by decreased Glomerular Filtration Rate (GFR).15 
The causes of AKI can be classified as: prerenal (reduced 
renal perfusion or hypovolemia), intrinsic renal (glomerular 
or tubular) and postrenal. The normal reference range of 
BCR is around 8-15 and the most commonly used threshold 
to interpret increased BCR is 20.16 For BCR >20 it is 
attributed to prerenal type whereas with BCR <20 can be 
due to renal or postrenal type.17,18,19 This elevation in BCR is 
one of the indicators of decreased renal perfusion. BCR can 
also be very handy in diagnosing gastrointestinal bleeding in 
some patients who do not present with overt blood loss.20-23 
Though now there is less evidence supporting BCR as a 
criterion to distinguish between these two conditions still we 
can use this as a reference when we do not have repeated 
blood values and GFR to diagnose a renal failure. The aim of 
the study was to find out the prevalence of renal impairment 
in the patients of liver cirrhosis with or without SBP. 
MATERIAL AND METHODS 
This was observational, prospective, single center study and 
was conducted at Department of Pharmacology, Maulana 
Azad medical college, Department of Gastroenterology and 
Department of Microbiology, Govind Ballabh Pant Institute of 
Postgraduate Medical Education and Research, New Delhi. A 
sample size of convenience of 32 patients was taken. The 
study was carried out after receiving approval from 
Departmental Scientific Committee and the Institutional 
Ethics Committee.  
Inclusion Criteria: 1) A patient of age above 18 and below 
75 years of either sex was included 2) A diagnosed case of 
SBP or a patient with protein in ascitic fluid less than 1.5 
gm/dl 
Methods: Consecutive patients that were already diagnosed 
with cirrhosis by the clinicians and satisfied the inclusion 
criteria were enrolled after taking proper informed consent 
from the Gastroenterology ward and Intensive Care Unit. On 
hospitalization, the patients underwent the required basic 
and specific investigations and were given the standard of 
care as per the hospital protocol and clinical judgment of the 
clinicians. The demographic data was enquired from the 
patient or from the patient relatives and serum creatinine 
and urea values of all included patients were collected from 
the investigation chart of the patient. Our aim was to find out 
the prevalence of renal impairment of cirrhotic patients on 
admission hence we did not take the repeated blood values 
of patients during their stay in the hospital. Renal 
impairment was considered if the serum creatinine (0.7-1.2 
mg/dl for males and 0.5-0.9 mg/dl in females by Jaffe kinetic 
method) or urea (<50 mg/dl by Urease GLDH method) or 
both were above the reference range. We converted the 
plasma urea values into BUN values using the formula:  
Blood urea nitrogen × 2.14 = blood urea  
The BUN values were further utilized to obtain the BCR 
which is given by formula: 
BCR= BUN (mg/dl)/Creatinine(mg/dl) 
We further a subgroup analysis and divided the patients on 
the basis of BCR criteria to with BCR <20 and BCR>20. To 
assess the variation of BCR values more thoroughly, they 
were further divided into eight subgroups according to BCR 
(<10, 10–15, 16–20, 21–25, 26–30, 31–35, 36-40 and >40). 
Statistical analysis 
The data was entered in MS Excel and was analyzed using 
statistical software SPSS version 20. The demographic data 
was presented as Mean + Standard deviation. The groups 
were compared using student’s unpaired t-test. Chi square 
test and Mann Whitney U Test were used to compare the 
data with non-normal distribution. A p value of <0.05 was 
considered significant.  
RESULTS 
A total of 34 patients were enrolled in the study who 
satisfied the inclusion criteria. They were further divided 
into two groups. 22 patients with diagnosed SBP were 
assigned Group A (SBP) and 12 patients with low ascitic fluid 
protein were assigned Group B(LA). The demographic data 
and blood parameters of the patients are summarized in the 
table 1. 
 
Table 1: Demographic variables and blood parameters of the patients 
 Group A Group B p value 
Age, Years(Mean ± SD) 51.86 ± 10.16 42.67 ± 10.93 p=0.71 
Sex, M/F 20/2 12/0  
Male, n(%) 90% 100%  
Serum Urea (mg/dL) 78.95±34.8 66.69±28.07 p=0.44 
Serum Creatnine (mg/dL) 1.44±0.60 1.35±0.32 p=0.75 
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All the parameters were equally matched as shown in the 
table 1. 
Both the groups were analyzed for assessment of renal 
impairment on the basis of serum urea and creatinine values 
and it was observed that there was no significant difference 
(p=0.24) between the two groups. Results are summarized in 
the table 2. 
 
Table 2: Assessment of renal impairment among the patients of liver cirrhosis 
 Total Patients Patients with Renal Impairment Percentage of Patients with Renal Impairment 
Group A (SBP) 22 17 77.27% 
Group B (LA) 12 7 58.33% 
Total 34 24 70.58% 
SBP= Spontaneous Bacterial Peritonitis, LA= low Ascitic fluid albumin 
 
The plasma urea was converted into BUN (mg/dl) for 
calculation of BCR in both the groups.       Both the groups 
were further analyzed on the basis of BCR and further 
subdivided into BCR<20 and BCR>20. Our study showed that 
majority of the patients were in the BCR>20 group which 
denotes a renal impairment of prerenal type. The results are 
summarized in table 3. 
 
Table 3: Table summarizing the patients on the basis of BUN:Creatinine Ratio (BCR) 
 BCR<20 BCR>20 
Group A 7 15 
Group B 7 5 
Total patients 14 20 
  
On further subdividing all the patients of both group on the 
basis of variable BCR (<10, 10–15, 16–20, 21–25, 26–30, 31–
35, 36-40 and >40) we found majority of the patients (12) in 
the BCR= 16-20 range. Seven patients in 21-25 range, six in 
26-30 range, three in 10-15 range, three in >40, two in 36-40 
and one in 31-35 range. The results are summarized in figure 
no. 1 
 
 
BCR= BUN:Creatinine Ratio 
Figure 1: Figure summarizing the variability and distribution of BCR among patients 
DISCUSSION 
Our study was conducted on 34 patients of liver cirrhosis 
with ascites having SBP or low ascitic fluid albumin to 
determine the prevalence of renal impairment in these 
patients. The demographic and blood parameters were 
matched. In the present study almost 70.58% of the patients 
had renal impairment which was denoted by elevated serum 
creatinine and/or urea values. Previous studies have shown 
that AKI has an estimated prevalence of about 20–50% 
among hospitalized patients with cirrhosis.4,24-27 The burden 
of renal impairment in patients with SBP was 77.27% which 
was more as compared to the patients without SBP (58.33%) 
which can be because of more deteriorating condition of the 
patient with SBP. Previous studies have shown about 33-
34% of patients with SBP are prone to develop renal 
failure.25,29 In our study we found an increased prevalence of 
renal impairment based on deranged renal parameters but 
could not ascertain it as a renal failure.  
On further classifying the patients on the basis of BCR, 
majority of the patients were in the BCR>20 group which 
shows they had a renal impairment of prerenal type which 
could be explained by the fact that there is effective decrease 
in blood volume in patients with cirrhosis and ascites leading 
to compromised renal perfusion.30,31 On subdividing the 
patients on the basis of BCR we found majority of the 
patients in the BCR=16-20 group which mostly denotes an 
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intrarenal pathology leading to impaired renal 
function.17,18,19 However we also found 3 patients who had 
BCR>40 which indicates towards a concealed or obvious 
gastrointestinal hemorrhage somewhere in the gut which is 
quite common in these patients of cirrhosis with ascites.20-23  
Though our study results indicates more towards prerenal 
type of injury, but we could not assure the fact as BCR 
criteria is not a precise criterion to diagnose renal injury. 
There are other superior criteria like RIFLE and AKIN which 
are more reliable as compared to BCR. Small sample size is 
another limitation in our study. However, our study gives an 
idea about the common occurrence of renal impairment in 
the patients of liver cirrhosis and ascites.    
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